Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2; Removed Revision: v3.2.0 from the history.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide government funding notice banner appears, indicating that information may not be up to date and that operations may be affected; it directs users to cc.nih.gov for operating status and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:14:36.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Updated study status is shown on the history page. Additional sections such as Adverse Events and Outcome Measures have been revised, reflecting ongoing updates to the NCT04098068 trial record.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:51.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    11%
    Check dated 2025-10-06T06:55:52.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:28:31.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed, with no other substantive changes.
    Difference
    0.7%
    Check dated 2025-09-14T21:38:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.